Pharma's Expenditure on R&D or Patents

R&D is no doubt basics for all drug producing industries.Now a days frequency of diseases simultaneously new drugs requirement is increasing some how so,without R & D no drug unit can be survived at all.Also if there is no new drug discovered than for what the patent will be applied ,so,researches and discoveries of new drugs are prime requirement of today.

It is vital in order to survive long term presence in the industry, R& D investments is the need of the hour. Till now, our domestic players were focussed in NDDS, or formulation research. But basic drug research has taken a backseat. Companies were only looking at a fast recovery for their investments as India lacked Product Patent rules, so most of the companies were going in for a Process Patent, in order to beat competition from MNCs. But today the scenario in India has changed, and it will be very important for the Indian companies to get into basic research, for which allocation of funds are crucial. An MNC annually invests somewhere between 4 to 8 % of thier budgets to R&D. It takes aound 15 to 20 years to develop a new drug. And its sad that none of any Indian companies have even a single new drug entity to their credit. Indian company's are going to take a backseat as Product Patents are now applicable in India, and hence they cannot offer generic versions any longer. Some MNCs have already launched their Patented Products....let's see where we go from here..Wait and watch !!

I know the bottom line is revenue but most of the co. revenue is spent on fighting on patents. The latest fight was between two co. for cancer drug and its patent.

I think it would help the patients a lot, more amount would be spend on to make better drugs rather than fighting on patents.